Nurofen is being sued for 'misleading customers'

Makers of the well-known painkiller, Nurofen, have been sued in Australia for 'misleading customers'. Nurofen, which is frequently taken to ease the likes of migraines, is made by British company Reckitt Benckiser, and they now face a fine of £890,000.

A court in Australia ruled last year that you cannot actually distinguish between pain relief aimed at specific areas of the body; because the content is identical. But Nurofen has a range of products targeted at various individual pains (such as migraine, tension headache, etc).

Advertisement - Continue Reading Below

One of the targeted pain relief range

Rex

Both the general pain relief products and targeted pain relief ones were found to contain exactly the same amount of the active ingredient, ibuprofen lysine. Oooh, the little swines.

Back in December, Reckitt Benckiser was ordered to change the packaging of these products, and The Australian Competition and Consumer Commission advised that they should be fined around $6 million Australian dollars (just over £3 million). But today it was announced the company had got off comparatively lightly, being ordered to pay $1.7million Australian dollars.

The courts have still come down hard on Nurofen, though, because they were found to be charging almost double the price of their general pain relief for the area-specific ones. Which isn't cool.

Advertisement - Continue Reading Below

But now we know, and hopefully Nurofen will have learnt its lesson. Or you could just do what I do and buy the cheapest pain relief going in the supermarkets. #BargainHunter.